LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that GlaxoSmithKline (GSK) has renewed its global multi-year license for Simulations Plus software and has added a new site at its Parsippany, NJ location.
